At the end of November 2023, the market capitalisation was $1.96B, an increase of $920M (89%) over the past 12 months. The MC was just shy of the all-time high of $1.97B.
The release of the first of the NNZ-2591 Phase 2 drug trial results are expected from December.
- Forums
- ASX - By Stock
- Market Capitalisation is a Better Valuation Metric Than Share Price
At the end of November 2023, the market capitalisation was...
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$22.14 |
Change
1.150(5.48%) |
Mkt cap ! $2.829B |
Open | High | Low | Value | Volume |
$21.50 | $22.44 | $21.50 | $13.15M | 598.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 437 | $22.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$22.15 | 8325 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2517 | 22.110 |
1 | 2576 | 22.090 |
1 | 500 | 22.080 |
1 | 1002 | 22.050 |
2 | 1019 | 22.040 |
Price($) | Vol. | No. |
---|---|---|
22.150 | 8118 | 6 |
22.170 | 1225 | 2 |
22.190 | 947 | 1 |
22.250 | 1019 | 2 |
22.270 | 25 | 1 |
Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |